SciClone Pharmaceuticals (Holdings) (HKSE:06600) Cash from Discontinued Operating Activities : HK$0 Mil (TTM As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

What is SciClone Pharmaceuticals (Holdings) Cash from Discontinued Operating Activities?

Cash from Discontinued Operating Activities is net cash from all of the entity's discontinued operating activities.

SciClone Pharmaceuticals (Holdings)'s Cash from Discontinued Operating Activities for the six months ended in Dec. 2023 was HK$0 Mil. It means SciClone Pharmaceuticals (Holdings) received HK$0 Mil from discontinued investing activities. SciClone Pharmaceuticals (Holdings)'s Cash from Discontinued Operating Activities for the trailing twelve months (TTM) ended in Dec. 2023 was HK$0 Mil.

SciClone Pharmaceuticals (Holdings) Cash from Discontinued Operating Activities Historical Data

The historical data trend for SciClone Pharmaceuticals (Holdings)'s Cash from Discontinued Operating Activities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

SciClone Pharmaceuticals (Holdings) Cash from Discontinued Operating Activities Chart

SciClone Pharmaceuticals (Holdings) Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Cash from Discontinued Operating Activities

Get a 7-Day Free Trial

SciClone Pharmaceuticals (Holdings) Semi-Annual Data
	Dec17	Dec18	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Cash from Discontinued Operating Activities	Get a 7-Day Free Trial						-	-	-	-	-

SciClone Pharmaceuticals (Holdings) Cash from Discontinued Operating Activities Calculation

Cash from Discontinued Operating Activities is net cash from all of the entity's discontinued operating activities.

Cash from Discontinued Operating Activities for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$0 Mil.

SciClone Pharmaceuticals (Holdings) Cash from Discontinued Operating Activities Related Terms

Thank you for viewing the detailed overview of SciClone Pharmaceuticals (Holdings)'s Cash from Discontinued Operating Activities provided by GuruFocus.com. Please click on the following links to see related term pages.

SciClone Pharmaceuticals (Holdings) (HKSE:06600) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » SciClone Pharmaceuticals (Holdings) Ltd (HKSE:06600) » Definitions » Cash from Discontinued Operating Activities

Traded in Other Exchanges

N/A

Address

381 Middle Huaihai Road, 22nd Floor, Central Plaza, Shanghai, CHN

Website

https://www.sciclone.com

SciClone Pharmaceuticals (Holdings) Ltd is a biopharmaceutical company with an integrated platform for product development and commercialization. It strategically focuses on some of the fast-growing therapeutic areas with unmet medical needs in China, primarily including oncology and severe infection. It generated revenue primarily from the sale of Zadaxin to Sinopharm.

SciClone Pharmaceuticals (Holdings) (HKSE:06600) Headlines

No Headlines